Page 4 - Genevant Sciences News Today

The Federal Circuits decision does not affect an ongoing lawsuit filed by Arbutus and Genevant Sciences - a joint venture between Arbutus and Roivant Sciences Ltd - against Moderna last year in...

A US appeals court handed Moderna a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma patent related to the companies legal fight over Modernas blockbuster COVID-19 vaccines.

A U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp patent related to the companies legal fight over Modernas blockbuster COVID-19... | April 11, 2023

A U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp patent related to the companies' legal fight over Moderna's blockbuster COVID-19 vaccines.

By Blake Brittain (Reuters) -A U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp patent ...

Pfizer used technologies developed by another company in its COVID-19 vaccine, infringing on patents, according to a new ...

None Arbutus Biopharma Corporation (NASDAQ: ABUS) and its licensee Genevant Sciences have sued Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ:…

Vice Chancellor Nathan Cook of the Delaware Chancery Court said the purchase agreement "clearly and unambiguously" left Merck liable for claims related to products, including Dr. Scholl's foot powder, sold before the transaction closed. Gilead details promising early COVID antiviral data, setting up larger studies Gilead Sciences Inc on Tuesday unveiled data from the first human study of its experimental oral COVID-19 antiviral, saying the results in healthy volunteers cleared th...

Arbutus Biopharma on Tuesday sued Pfizer and BioNTech in a New Jersey district court, claiming their mRNA COVID-19 vaccines infringe five of Arbutus patents.

Independent Community Bankers of America is rolling out a new campaign aimed at shoring up small lenders in the wake of last month’s bank collapses.